Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 58Gastrointestinal 37Thoracic 32Genitourinary 22Gynecologic 18Other solid neoplasm 17Tumor-Agnostic 15Other hematologic neoplasm 14Lymphoid 13Other 12Dermatologic 12Other neoplasm 6Head & Neck 6Plasma cell 5CNS 3Sarcoma 2Myeloid 2Classical hematology 2

Conditions

Sarcoma 2

Interventions

Radiotherapy 137Cyclophosphamide 132Temozolomide 116Doxorubicin 99Filgrastim 68Ifosfamide 64Gemcitabine 58Etoposide 55Bevacizumab 51Imatinib Mesylate 50fludarabine phosphate 49Irinotecan 46pembrolizumab 45Peripheral Blood Stem Cell Transplantation 45pazopanib 43Magnetic Resonance Spectroscopy 42Methotrexate 40Carboplatin 40Busulfan 40Vincristine 38Surgical Procedures, Operative 37Nivolumab 37Melphalan 37Cisplatin 36Radiation 34Blood Specimen Collection 33Mycophenolic Acid 31Cyclosporine 31Docetaxel 29Trabectedin 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Educational Status × Sarcoma × Clear all
NCT05526417 2026-01-16

Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma

Mayo Clinic

Phase NA Recruiting
30 enrolled
Sarcoma

Sarcoma

NCT03258892 2022-09-28

Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy

Ohio State University Comprehensive Cancer Center

Phase NA Completed
64 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡